4//SEC Filing
Quimi Daphne 4
Accession 0001062993-22-020144
CIK 0001850119other
Filed
Oct 2, 8:00 PM ET
Accepted
Oct 3, 4:08 PM ET
Size
5.3 KB
Accession
0001062993-22-020144
Insider Transaction Report
Form 4
Quimi Daphne
Director
Transactions
- Award
Stock Option (right to buy)
2022-10-01+39,744→ 39,744 totalExercise: $9.89Exp: 2032-10-01→ Common Stock (39,744 underlying)
Footnotes (1)
- [F1]Century Therapeutics, Inc. (the "Company") issued Ms. Quimi stock options (the "Options") in connection with her appointment as a director. The Options vest in equal monthly installments over 36 months subject to Ms. Quimi's continued service to the Company and are issued pursuant to the Company's 2021 Equity Incentive Plan.
Issuer
Century Therapeutics, Inc.
CIK 0001850119
Entity typeother
Related Parties
1- filerCIK 0001543031
Filing Metadata
- Form type
- 4
- Filed
- Oct 2, 8:00 PM ET
- Accepted
- Oct 3, 4:08 PM ET
- Size
- 5.3 KB